🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07154303
Enrolling by invitation Observational

Testing the Performance of Smartphones and Their Accessories in Detecting Irregularly Irregular Heart Rhythm

NCT07154303 · tracked via the Priya Life Science China tracker
Sponsor
The University of Hong Kong
Phase
Observational
Started
2025-08-27
Last updated
2025-12-31

Condition(s) studied

Atrial Fibrillation (AF)

Investigational drug(s) / intervention(s)

Computer algorithms

Computer algorithms: Computer algorithms that are designed to perform heart sound, electrocardiography (ECG), and/or facial photoplethysmography (rPPG) analysis on data collected from smartphone's internal hardware and/or external accessories.

Study summary

The purpose of this 4-in-1 observational study is to test the performance of artificial intelligences (AIs) in distinguishing irregularly irregular heart rhythm called atrial fibrillation (AF) from normal heart rhythm using physiological signals collected by smartphones' built-in hardware and/or external accessories.

Participants will:

* Have their weight, height, resting heart rate and blood pressures measured
* Have 12-lead electrocardiogram (ECG) of their heart electrical activities recorded
* Have their heart sounds and 1-lead ECG recorded from their chest, and optical-based blood flow data (photoplethysmography or PPG) and 1-lead ECG recorded from their fingers using smartphones' built-in microphone, camera, and/or external accessories
* Optionally have their optical-based blood flow data recorded from their face using smartphones' built-in camera (remote PPG or rPPG).

The researchers will also create a database containing the physiological signals collected in this study along with the participants' medically relevant information to help train and test future AIs for medical applications.

Eligibility

Sex
ALL
Min age
22 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age: ≥22 years (adult) * Patients who have one of the following: * Permanent atrial fibrillation, or * Long-standing persistent atrial fibrillation (12 months or longer), or * Confirmed 12-lead ECG diagnosis for persistent atrial fibrillation (\> 7 days) or sinus rhythm within 12 months at the time of their normal attendance at the hospital Exclusion Criteria: Any of the following: * Implanted active medical devices in the torso, such as pacemakers and defibrillators * Patients without atrial fibrillation who have another arrhythmia * Completely missing one or more limbs, or missing any hand * Disability in using their hands or arms * Lack of both index fingers, or all fingers in any hand * Both index fingers with any of the following characteristics: * Tattooed/inked * Reduced blood flow in the fingertip (e.g. perniosis or callus formation)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Queen Mary Hospital Hong Kong China

More The University of Hong Kong trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07154303 on ClinicalTrials.gov ↗ ← All trials in China